Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review of lung cancer with breast metastasis.

Journal of thoracic disease·2025
Same author

Navigating the challenges of artificial intelligence integration in thoracic surgery.

Current challenges in thoracic surgery·2025
Same author

Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

A Case Report of Concurrent Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719A) and Exon 21 (L833_V834delinsFL) Mutations and Treatment Challenges.

Cureus·2024
Same author

Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacities.

The Journal of thoracic and cardiovascular surgery·2024
Same author

First report of a post-pneumonectomy nocardia empyema.

Journal of surgical case reports·2024

Related Experiment Video

Updated: Jun 19, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Mesothelioma: path to multimodality treatment.

Stacey Su1

  • 1Department of Surgery, University of Pennsylvania School of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA. Stacey.Su@uphs.upenn.edu

Seminars in Thoracic and Cardiovascular Surgery
|October 14, 2009
PubMed
Summary

Multimodality treatment offers the best survival for malignant pleural mesothelioma (MPM). However, disease recurrence remains a challenge, necessitating further research into targeted therapies and improved patient selection for better outcomes.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jun 19, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Background:

  • Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited treatment options.
  • Multimodality treatment (surgery, radiation, chemotherapy) is the current standard for select patients.
  • Disease recurrence, particularly in the ipsilateral hemithorax, remains a significant challenge.

Purpose of the Study:

  • To review the current state of multimodality treatment for MPM.
  • To highlight the challenges and future directions in managing MPM.
  • To explore innovative therapeutic strategies for improving patient survival.

Main Methods:

  • Review of existing literature on MPM treatment strategies.
  • Analysis of multimodality approaches including surgery, radiation, and chemotherapy.
  • Exploration of novel therapeutic modalities and diagnostic tools.

Main Results:

  • Multimodality treatment provides the only avenue for extended survival in select MPM patients.
  • No single-modality approach has achieved comparable results to combined therapies.
  • Despite progress, disease recurrence remains a primary obstacle to cure.

Conclusions:

  • Further refinement in patient selection and targeted therapies holds promise for improved MPM survival.
  • Innovative approaches like gene therapy, immunotherapy, and photodynamic therapy are under investigation.
  • Accurate diagnosis and prognostication using gene ratios may enable more selective treatment assignment.